Jun Mori

1.6k total citations
18 papers, 1.1k citations indexed

About

Jun Mori is a scholar working on Hematology, Molecular Biology and Immunology. According to data from OpenAlex, Jun Mori has authored 18 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 8 papers in Molecular Biology and 7 papers in Immunology. Recurrent topics in Jun Mori's work include Platelet Disorders and Treatments (12 papers), Protein Tyrosine Phosphatases (6 papers) and Cell Adhesion Molecules Research (6 papers). Jun Mori is often cited by papers focused on Platelet Disorders and Treatments (12 papers), Protein Tyrosine Phosphatases (6 papers) and Cell Adhesion Molecules Research (6 papers). Jun Mori collaborates with scholars based in United Kingdom, United States and Germany. Jun Mori's co-authors include Yotis A. Senis, Alexandra Mazharian, Steve P. Watson, Alice Y. Pollitt, Johannes A. Eble, Benjamin G. Neel, Craig E. Hughes, Silke Heising, Michael G. Tomlinson and John H. Hartwig and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Blood.

In The Last Decade

Jun Mori

18 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jun Mori United Kingdom 16 529 370 305 164 147 18 1.1k
Alexandra Mazharian United Kingdom 21 717 1.4× 433 1.2× 282 0.9× 202 1.2× 167 1.1× 33 1.3k
Lia Guidotti Italy 16 240 0.5× 378 1.0× 189 0.6× 204 1.2× 51 0.3× 27 964
Susana Larrucea Spain 15 234 0.4× 299 0.8× 164 0.5× 71 0.4× 94 0.6× 27 750
Lisa Nannizzi‐Alaimo United States 11 516 1.0× 224 0.6× 155 0.5× 375 2.3× 429 2.9× 12 1.1k
Seiichiro Tarui Japan 17 278 0.5× 523 1.4× 375 1.2× 44 0.3× 112 0.8× 40 1.3k
Jeanny Ohan France 6 179 0.3× 414 1.1× 416 1.4× 163 1.0× 91 0.6× 10 1.0k
C. Pérez‐Sánchez Spain 23 249 0.5× 605 1.6× 511 1.7× 82 0.5× 60 0.4× 70 1.6k
Tingliang Shen United States 9 214 0.4× 475 1.3× 72 0.2× 117 0.7× 93 0.6× 18 1.1k
F Shimizu Japan 20 92 0.2× 596 1.6× 272 0.9× 71 0.4× 115 0.8× 54 1.3k
Harlan N. Bradford United States 18 533 1.0× 203 0.5× 211 0.7× 64 0.4× 38 0.3× 39 979

Countries citing papers authored by Jun Mori

Since Specialization
Citations

This map shows the geographic impact of Jun Mori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Mori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Mori more than expected).

Fields of papers citing papers by Jun Mori

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Mori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Mori. The network helps show where Jun Mori may publish in the future.

Co-authorship network of co-authors of Jun Mori

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Mori. A scholar is included among the top collaborators of Jun Mori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Mori. Jun Mori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Senis, Yotis A., et al.. (2021). Platelet Src family kinases: A tale of reversible phosphorylation. Research and Practice in Thrombosis and Haemostasis. 5(3). 376–389. 7 indexed citations
2.
Nagy, Zoltán, et al.. (2020). Interplay between the tyrosine kinases Chk and Csk and phosphatase PTPRJ is critical for regulating platelets in mice. Blood. 135(18). 1574–1587. 16 indexed citations
3.
Garcia, Cédric, Thomas Édouard, Sophie Voisin, et al.. (2019). Catalytic dysregulation of SHP2 leading to Noonan syndromes affects platelet signaling and functions. Blood. 134(25). 2304–2317. 20 indexed citations
4.
Nagy, Zoltán, Timo Vögtle, Mitchell J. Geer, et al.. (2018). The Gp1ba-Cre transgenic mouse: a new model to delineate platelet and leukocyte functions. Blood. 133(4). 331–343. 43 indexed citations
5.
Mori, Jun, Zoltán Nagy, Christopher W. Smith, et al.. (2018). Maintenance of murine platelet homeostasis by the kinase Csk and phosphatase CD148. Blood. 131(10). 1122–1144. 32 indexed citations
6.
Mori, Jun, Zoltán Nagy, Helen Philippou, et al.. (2018). Evaluation of the Total Thrombus-Formation System (T-TAS): application to human and mouse blood analysis. Platelets. 30(7). 893–900. 27 indexed citations
7.
Senis, Yotis A., Alexandra Mazharian, & Jun Mori. (2014). Src family kinases: at the forefront of platelet activation. Blood. 124(13). 2013–2024. 206 indexed citations
8.
Gitz, Eelo, Alice Y. Pollitt, Jerney J. Gitz-Francois, et al.. (2014). CLEC-2 expression is maintained on activated platelets and on platelet microparticles. Blood. 124(14). 2262–2270. 89 indexed citations
9.
Mazharian, Alexandra, Jun Mori, Yingjie Wang, et al.. (2013). Megakaryocyte-specific deletion of the protein-tyrosine phosphatases Shp1 and Shp2 causes abnormal megakaryocyte development, platelet production, and function. Blood. 121(20). 4205–4220. 61 indexed citations
10.
Séverin, Sonia, Craig A. Nash, Jun Mori, et al.. (2012). Distinct and overlapping functional roles of Src family kinases in mouse platelets. Journal of Thrombosis and Haemostasis. 10(8). 1631–1645. 42 indexed citations
11.
Mazharian, Alexandra, Jun Mori, Danai Bem, et al.. (2012). Mice Lacking the ITIM-Containing Receptor G6b-B Exhibit Macrothrombocytopenia and Aberrant Platelet Function. Science Signaling. 5(248). ra78–ra78. 68 indexed citations
12.
Mori, Jun, Yingjie Wang, Stuart Ellison, et al.. (2012). Dominant Role of the Protein-Tyrosine Phosphatase CD148 in Regulating Platelet Activation Relative to Protein-Tyrosine Phosphatase-1B. Arteriosclerosis Thrombosis and Vascular Biology. 32(12). 2956–2965. 26 indexed citations
13.
Hughes, Craig E., et al.. (2011). Tityus discrepans scorpion venom activates platelets through GPVI and a novel Src-dependent signaling pathway. Platelets. 22(3). 165–172. 8 indexed citations
14.
Karisch, Robert, Minerva Fernandez, Paul Taylor, et al.. (2011). Global Proteomic Assessment of the Classical Protein-Tyrosine Phosphatome and “Redoxome”. Cell. 146(5). 826–840. 141 indexed citations
15.
Ellison, Stuart, Jun Mori, A. Barr, & Yotis A. Senis. (2010). CD148 enhances platelet responsiveness to collagen by maintaining a pool of active Src family kinases. Journal of Thrombosis and Haemostasis. 8(7). 1575–1583. 27 indexed citations
16.
Hughes, Craig E., Alice Y. Pollitt, Jun Mori, et al.. (2010). CLEC-2 activates Syk through dimerization. Blood. 115(14). 2947–2955. 114 indexed citations
17.
Mori, Jun, et al.. (2009). The novel Syk inhibitor R406 reveals mechanistic differences in the initiation of GPVI and CLEC‐2 signaling in platelets. Journal of Thrombosis and Haemostasis. 7(7). 1192–1199. 76 indexed citations
18.
Mori, Jun, Andrew C. Pearce, Beata Grygielska, et al.. (2008). G6b-B Inhibits Constitutive and Agonist-induced Signaling by Glycoprotein VI and CLEC-2. Journal of Biological Chemistry. 283(51). 35419–35427. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026